Correlation Between Viking Therapeutics and Acumen Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Viking Therapeutics and Acumen Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viking Therapeutics and Acumen Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viking Therapeutics and Acumen Pharmaceuticals, you can compare the effects of market volatilities on Viking Therapeutics and Acumen Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viking Therapeutics with a short position of Acumen Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viking Therapeutics and Acumen Pharmaceuticals.
Diversification Opportunities for Viking Therapeutics and Acumen Pharmaceuticals
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Viking and Acumen is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Viking Therapeutics and Acumen Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acumen Pharmaceuticals and Viking Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viking Therapeutics are associated (or correlated) with Acumen Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acumen Pharmaceuticals has no effect on the direction of Viking Therapeutics i.e., Viking Therapeutics and Acumen Pharmaceuticals go up and down completely randomly.
Pair Corralation between Viking Therapeutics and Acumen Pharmaceuticals
Given the investment horizon of 90 days Viking Therapeutics is expected to generate 0.65 times more return on investment than Acumen Pharmaceuticals. However, Viking Therapeutics is 1.53 times less risky than Acumen Pharmaceuticals. It trades about -0.31 of its potential returns per unit of risk. Acumen Pharmaceuticals is currently generating about -0.31 per unit of risk. If you would invest 6,297 in Viking Therapeutics on September 12, 2024 and sell it today you would lose (1,376) from holding Viking Therapeutics or give up 21.85% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viking Therapeutics vs. Acumen Pharmaceuticals
Performance |
| Timeline |
| Viking Therapeutics |
| Acumen Pharmaceuticals |
Viking Therapeutics and Acumen Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viking Therapeutics and Acumen Pharmaceuticals
The main advantage of trading using opposite Viking Therapeutics and Acumen Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viking Therapeutics position performs unexpectedly, Acumen Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acumen Pharmaceuticals will offset losses from the drop in Acumen Pharmaceuticals' long position.| Viking Therapeutics vs. Terns Pharmaceuticals | Viking Therapeutics vs. Akero Therapeutics | Viking Therapeutics vs. Madrigal Pharmaceuticals | Viking Therapeutics vs. Sarepta Therapeutics |
| Acumen Pharmaceuticals vs. Equillium | Acumen Pharmaceuticals vs. DiaMedica Therapeutics | Acumen Pharmaceuticals vs. Valneva SE ADR | Acumen Pharmaceuticals vs. Vivani Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Stocks Directory Find actively traded stocks across global markets |